| Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats EC Onwordi, EF Halff, T Whitehurst, A Mansur, MC Cotel, L Wells, ... Nature communications 11 (1), 246, 2020 | 180 | 2020 |
| The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis OD Howes, T Whitehurst, E Shatalina, L Townsend, EC Onwordi, ... World Psychiatry 20 (1), 75-95, 2021 | 131 | 2021 |
| Proton magnetic resonance spectroscopy of N-acetyl aspartate in chronic schizophrenia, first episode of psychosis and high-risk of psychosis: a systematic review and meta-analysis TS Whitehurst, M Osugo, L Townsend, E Shatalina, R Vava, EC Onwordi, ... Neuroscience & Biobehavioral Reviews 119, 255-267, 2020 | 42 | 2020 |
| The synaptic hypothesis of schizophrenia version III: a master mechanism OD Howes, EC Onwordi Molecular Psychiatry 28 (5), 1843-1856, 2023 | 35 | 2023 |
| The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and … EC Onwordi, T Whitehurst, A Mansur, B Statton, A Berry, M Quinlan, ... Translational psychiatry 11 (1), 393, 2021 | 34 | 2021 |
| Neurofunctional correlates of glutamate and GABA imbalance in psychosis: A systematic review U Zahid, EC Onwordi, EP Hedges, MB Wall, G Modinos, RM Murray, ... Neuroscience & Biobehavioral Reviews 144, 105010, 2023 | 12 | 2023 |
| Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat. Commun. 11, 246 EC Onwordi, EF Halff, T Whitehurst, A Mansur, MC Cotel, L Wells, ... | 11 | 2020 |
| The effects of acute Δ9-tetrahydrocannabinol on striatal glutamatergic function: A proton magnetic resonance spectroscopy study MAP Bloomfield, K Petrilli, R Lees, C Hindocha, K Beck, RJ Turner, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 6 (6), 660-667, 2021 | 5 | 2021 |
| Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun 11 (1): 246 EC Onwordi, EF Halff, T Whitehurst, A Mansur, MC Cotel, L Wells, ... | 5 | 2020 |
| Synaptic terminal density early in the course of schizophrenia: An in vivo UCB-J positron emission tomographic imaging study of SV2A EC Onwordi, T Whitehurst, E Shatalina, A Mansur, A Arumuham, M Osugo, ... Biological psychiatry 95 (7), 639-646, 2024 | 4 | 2024 |
| Trends in mortality in schizophrenia and their implications E Onwordi, O Howes Acta Psychiatrica Scandinavica 138 (6), 489-491, 2018 | 4 | 2018 |
| The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia A Arumuham, MM Nour, M Veronese, EC Onwordi, EA Rabiner, ... Journal of Psychopharmacology 37 (10), 1011-1022, 2023 | 3 | 2023 |
| Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study E Shatalina, TS Whitehurst, EC Onwordi, BJ Gilbert, G Rizzo, ... EJNMMI research 14 (1), 41, 2024 | | 2024 |
| Histamine-3 receptor availability and glutamate levels in the brain: a PET-1H-MRS study of patients with schizophrenia and healthy controls A Arumuham, MM Nour, M Veronese, K Beck, EC Onwordi, DJ Lythgoe, ... International Journal of Neuropsychopharmacology, pyae011, 2024 | | 2024 |
| Synaptic Density Marker, SV2A, Is Reduced in Autistic Adults C Mehra, E Onwordi, B Kowalewska, T Whitehurst, E Shatalina, ... INSAR 2023, 2023 | | 2023 |
| 5. Effects of Sustained D2 Receptors Blockade on Brain Structure and Function in Healthy Volunteers P Selvaggi, M Osugo, O Dipasquale, U Zahid, T Whitehurst, E Onwordi, ... Biological Psychiatry 93 (9), S95-S96, 2023 | | 2023 |
| The Relationship Between Synaptic and Cognitive Markers in Schizophrenia: A Positron Emission Tomography Study Using [11 C] UCB-J E Onwordi, T Whitehurst, E Shatalina, A Mansur, A Arumuham, M Osugo, ... NEUROPSYCHOPHARMACOLOGY 47 (SUPPL 1), 341-341, 2022 | | 2022 |
| Subchronic amisulpride administration induces negative symptoms and reduces reward activation in healthy individuals M Osugo, U Zahid, P Selvaggi, M Wall, T Whitehurst, E Onwordi, B Statton, ... Neuroscience Applied 1, 100094, 2022 | | 2022 |
| Mitochondrial complex I availability is reduced in schizophrenia: a positron emission tomography study T Whitehurst, E Onwordi, A Mansur, E Shatalina, S Natesan, B Statton, ... Neuroscience Applied 1, 100069, 2022 | | 2022 |
| Synaptic Dysfunction in Schizophrenia and the Effects of Treatment: Complementary in Vivo Clinical and Preclinical Studies O Howes, E Onwordi, T Whitehurst, E Shatalina, E Halff, S Natesan, ... Biological Psychiatry 89 (9), S34-S35, 2021 | | 2021 |
